Skip to content

In the BioHarmony Drug Report Database

Secretin

Secretin-ferring (secretin) is a protein pharmaceutical. Secretin was first approved as Secretin-ferring on 1982-01-01. The pharmaceutical is active against secretin receptor. In addition, it is known to target pituitary adenylate cyclase-activating polypeptide type I receptor, vasoactive intestinal polypeptide receptor 2, and vasoactive intestinal polypeptide receptor 1.
Trade Name Secretin-ferring
Common Name Secretin
Indication
Drug Class Retinol derivatives
Secretin
Get full access now